Pharmacist-led services for skin conditions and related physician visits in Ontario
Iskandar RJ, Ghahramani D, Jaakkimainen L, Nakhla N, Tadrous M, Drucker AM. J Cutan Med Surg. 2026; Jul 27 [Epub ahead of print].
Publications
Safety of antibiotic audit and feedback: secondary analysis of a randomized controlled trial
Schwartz KL, Bai L, Brown KA, Tadrous M, Grimshaw JM, Witteman HO, Friedman L, Langford BJ, Leung V, Gomes T, Garber G, Taljaard M, Shuldiner J, Gushue S, Silverman M, Daneman N, Brehaut J, Presseau J, Leis JA, Lacroix M, Zwarenstein M, Masucci L, Thavorn K, Ivers N. J Antimicrob Chemother. 2026; 81(7): dkag216.
Geographic variation and neighbourhood correlates of mental health-related hospitalizations and emergency department visits in children and youth during the COVID-19 pandemic: a population-based study
Antoniou T, Gozdyra P, Fridman D, Pajer K, Gomes T, Penner M, Tadrous M, Juurlink DN, Gardner W. Front Child Adolesc Psychiatry. 2026; 5:1575531.
Real-world trends in prenatal antirheumatic drug utilization in Ontario, Canada: a cross-sectional time-series analysis
Tharmarajah S, Hussain S, Guilcher SJT, McCarthy LM, Mahendira D, Berger H, Tadrous M. Arthritis Care Res (Hoboken). 2026; Apr 28 [Epub ahead of print].
Evaluating equitable access based on sociodemographic predictors of nirmatrelvir-ritonavir use during the first year of availability in Ontario, Canada: a population-based ecological study
Lacroix M, Langford BJ, Chen C, Wang J, Tadrous M, Daneman N, Leung V, Gomes T, Friedman L, Daley P, Brown KA, Schwartz KL. Can J Public Health. 2026; Apr 13 [Epub ahead of print].
Opioid toxicity following concomitant use of macrolide antibiotics with fentanyl, hydromorphone, or oxycodone: a population-based study
Antoniou T, Yang J, Juurlink DN, Ho JM, Mamdani M, Wu F, Tadrous M, Gomes T. Clin Pharmacol Ther. 2026; Apr 7 [Epub ahead of print].
Impact of billing policy changes on telehealth use in Ontario: a population-based repeated cross-sectional study
Stamenova V, Chu C, Fang J, Bhattacharyya O, Bhatia RS, Tadrous M. Health Policy Technol. 2026; 15(2026): 101214.
Mailed audit and feedback for antibiotic prescribing in primary care
Masucci L, Schwartz K, Ivers N, Bai L, Brown K, Tadrous M, Grimshaw JM, Witteman HO, Friedman L, Langford BJ, Leung V, Gomes T, Garber G, Taljaard M, Shuldiner J, Gushue S, Silverman M, Daneman N, Brehaut J, Presseau J, Leis JA, Lacroix M, Zwarenstein M, Thavorn K. JAMA Netw Open. 2026; 9(3): e261641.
Patterns of prescription stimulant initiation before and during the COVID-19 pandemic: a population-based time series analysis
Gomes T, Wang T, Rebić N, Miller S, Paolozza L, Vigod SN, Tadrous M. CMAJ. 2026; 198(9): E313-E325.
Measuring the impact of the substitution of innovator biologics with biosimilars on uptake and costs among Ontario public drug benefit recipients
Iacono A, Ho M, Yang J, Campbell T, Wynne W, Shearer D, Andersen L, Majer E, Ledlie S, Tadrous M, Gomes T. Clin Pharmacol Ther. 2026; Jan 27 [Epub ahead of print].